feed,title,long_url,short_url
Benzinga,FDA Approves Regeneron and Sanofi's Dupixent (dupilumab) For Eosinophilic Esophagitis (EoE) Ahead of Schedule,https://benzinga.com/general/biotech/22/05/27333486/fda-approves-regeneron-and-sanofis-dupixent-dupilumab-for-eosinophilic-esophagitis-eoe-ahead-of-s,https://bit.ly/3yVdQMp
